Ronald A. Pepin's most recent trade in Celldex Therapeutics Inc. was a trade of 11,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 11,000 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 15 Dec 2025 | 11,000 | 20,097 (0%) | 0% | 2.8 | 30,580 | Common Stock |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 8,333 | 5,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 15 Dec 2025 | 8,333 | 9,097 (0%) | 0% | 9.0 | 75,134 | Common Stock |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 20,000 | 20,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 20,000 | 20,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc | Ronald A. Pepin | Sr. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,500 | 15,500 | - | - | Incentive Stock Option (right to buy) |